Archived - For The Public - Important Safety And Efficacy Information On Iressa (gefitinib) 250 Mg Tablets
Iressa (gefitinib) 250 mg Tablets Recall Summary Iressa 250 mg tablets have been recalled in Canada due to safety and efficacy concerns with the medication. This recall affects all patients in Canada who have been prescribed this drug. The recall applies to gefitinib tablets at the 250 mg dose strength distributed across the country.
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2006-08-26
- Status
- Closed
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/c493cadd-0541-4919-924e-1272ba1b7896